Rob Sahr was quoted by Managing IP in an article titled “Pharma fears corruption of ‘hugely successful’ Bayh-Dole Act.” Read more (subscription required).
This article comes off the heels of a panel Rob served on titled “Pharmaceutical Innovations: Patents and the Politics of COVID-19,” which was organized by The Indiana University Maurer School of Law, Eli Lilly & Co. and Roche.